Stringent criteria for histological diagnosis of koilocytosis fail to eliminate overdiagnosis of human papillomavirus infection and cervical intraepithelial neoplasia grade 1

被引:24
作者
Abadi, MA
Ho, GYF
Burk, RD
Romney, SL
Kadish, AS
机构
[1] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA
[4] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[5] Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10461 USA
关键词
human papillomavirus; cervical intraepithelial neoplasia; koilocytosis; squamous intraepithelial lesion; overdiagnosis;
D O I
10.1016/S0046-8177(98)90390-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Overdiagnosis of HPV infection in cervical biopsies results in increased health care costs and unnecessary surgical procedures. Stringent criteria for histological diagnosis of koilocytosis were evaluated, using molecular detection of HPV DNA (polymerase chain reaction and Southern blot hybridization) as gold standard. Colposcopic biopsy specimens from 511 patients were studied, including 76 with referral diagnoses of negative cervix and 241 with CIN 1 or koilocytosis. Referral diagnoses for low-grade lesions failed to distinguish between HPV-infected and uninfected patients. False-positive rate for prediction of HPV infection was 74.8%. Biopsy specimens reevaluated using stringent diagnostic criteria showed increasing prevalence of HPV infection among patients whose biopsy specimens showed negative (43.7%), minimal (52.4%), or definite (69.5%) features of koilocytosis (P = .001). Similarly, subjects infected with high viral load or oncogenic HPV infection were more likely to be identified (P = .004 and .04, respectively). Despite increased predictive value of stringent diagnostic criteria, significant number of patients diagnosed as having CIN 1/koilocytosis (34.0%) did not in fact have HPV infection. Because most low-grade lesions spontaneously regress, patients with histological diagnosis of CIN 1 or HPV infection should be observed for a period of several months before definitive ablative treatment is undertaken. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:54 / 59
页数:6
相关论文
共 38 条
[1]  
ADACHI A, 1993, OBSTET GYNECOL, V81, P372
[2]  
AMBROS RA, 1990, SEMIN DIAGN PATHOL, V7, P158
[3]   PAPILLOMAVIRUSES AND HUMAN CANCER [J].
ARENDS, MJ ;
WYLLIE, AH ;
BIRD, CC .
HUMAN PATHOLOGY, 1990, 21 (07) :686-698
[4]   A NEW TYPE OF PAPILLOMAVIRUS DNA, ITS PRESENCE IN GENITAL CANCER BIOPSIES AND IN CELL-LINES DERIVED FROM CERVICAL-CANCER [J].
BOSHART, M ;
GISSMANN, L ;
IKENBERG, H ;
KLEINHEINZ, A ;
SCHEURLEN, W ;
HAUSEN, HZ .
EMBO JOURNAL, 1984, 3 (05) :1151-1157
[5]   Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women [J].
Burk, RD ;
Ho, GYF ;
Beardsley, L ;
Lempa, M ;
Peters, M ;
Bierman, R .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :679-689
[6]  
CHAPMAN WB, 1993, MODERN PATHOL, V6, P73
[7]   PATHOLOGIST VARIATION IN REPORTING CERVICAL BORDERLINE EPITHELIAL ABNORMALITIES AND CERVICAL INTRAEPITHELIAL NEOPLASIA [J].
CREAGH, T ;
BRIDGER, JE ;
KUPEK, E ;
FISH, DE ;
MARTINBATES, E ;
WILKINS, MJ .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (01) :59-60
[8]   PAPILLOMAVIRUS SEQUENCES INTEGRATE NEAR CELLULAR ONCOGENES IN SOME CERVICAL CARCINOMAS [J].
DURST, M ;
CROCE, CM ;
GISSMANN, L ;
SCHWARZ, E ;
HUEBNER, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (04) :1070-1074
[9]   HUMAN PAPILLOMAVIRUS DNA IN NORMAL, METAPLASTIC, PRENEOPLASTIC AND NEOPLASTIC EPITHELIA OF THE CERVIX UTERI [J].
FUCHS, PG ;
GIRARDI, F ;
PFISTER, H .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) :41-45
[10]   PERSISTENT GENITAL HUMAN PAPILLOMAVIRUS INFECTION AS A RISK FACTOR FOR PERSISTENT CERVICAL DYSPLASIA [J].
HO, GYF ;
BURK, RD ;
KLEIN, S ;
KADISH, AS ;
CHANG, CJ ;
PALAN, P ;
BASU, J ;
TACHEZY, R ;
LEWIS, R ;
ROMNEY, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (18) :1365-1371